|
|
|
|
| Advertisement |
 |
|
|
|
|
/ March 8-11, 2020: Pharma Forum 2020
/ |
|
New York City, NY |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress
/ |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020
/ |
|
Barcelona, Spain |
|
/ April 20–22, 2020: Digital Health for Pharma
/ |
|
Philadelphia, PA. |
|
/ April 29–May 1, 2020: Pharmaceutical Compliance Congress (PCC) 2020
/ |
|
Washington, D.C. |
|
/ June 14–18, 2020: DIA 2020 Global Annual Meeting
/ |
|
Washington, D.C. |
 |
|
| |
|
|
|
|
|
|
|
|
| Advertisement |
|
| |
| Industry update |
| //John Bournas has left his position as CEO and President of the International Society for Pharmaceutical Engineering (ISPE). The Board has appointed Tim Howard to assume the role as Acting CEO and President.
//
Kate DeVarney has joined Titan Pharmaceuticals’ (San Francisco, CA) Board of Directors, where she currently serves as Executive Vice President and Chief Scientific Officer.
//
Rubius Therapeutics (Cambridge, MA) appointed Christina Coughlin as Chief Medical Officer.
//
Dr. Ton Logtenberg stepped down as CEO, President, Principal Financial Officer and Director of Merus (Utrecht, The Netherlands and Cambridge, MA) on December 31. Sven (Bill) Ante Lundberg was named as the company’s new Chief Executive Officer. Dr. Logtenberg will remain on as a senior advisor during the transition over the next year.
|
|
|
|
|
|
|
|
|
Read More
